Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2012 New Report
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2012, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) therapeutic pipeline. This report provides information on the therapeutic development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Familial Hypercholesterolemia (Type II Hyperlipoproteinemia). 'Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2012' is built using data and information...
View full press release